Effects of Paclitaxel in Combination with Ionizing Radiation on Angiogenesis in the Chick Embryo Chorioallantoic Membrane: A Radiobiological Study

Strahlentherapie und Onkologie

Volumn 180, Issue 3, 2004, Pages 152-156

  Kardamakis, Dimitrios ^a   Hadjimichael, Christos ^a,c   Ginopoulos, Panagiotis ^b   Papaioannou, Stamatis ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY GENERAL HOSPITAL OF PATRAS   (Greece)

^c KES College   (Cyprus)

Author keywords

Angiogenesis; Chorioallantoic membrane; Paclitaxel; Radiobiology

Indexed keywords

PACLITAXEL;

ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EMBRYO; IONIZING RADIATION; NONHUMAN; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RADIOBIOLOGY; RADIOSENSITIZATION; TUMOR VASCULARIZATION;

ALLANTOIS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHICK EMBRYO; CHORION; DATA INTERPRETATION, STATISTICAL; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; NEOVASCULARIZATION, PHYSIOLOGIC; PACLITAXEL; RADIATION DOSAGE; RADIOBIOLOGY; RESEARCH; TIME FACTORS;

EID: 1542349962     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-004-1140-6     Document Type: Article

References (49)

1. Ankel E, Lai C, Hopwood L, et al. Cytotoxicity of commonly used nitroxide radical spin probes. Life Sci 1987;40:495-8.
2. Auerbach R, Auerbach W, Polakowski I. Assays for angiogenesis: a review. Pharmacol Ther 1991;51:1-11.
3. Burton G, Palmer M. Development of the chick chorioallantoic capillary plexus under normoxic and normobaric hypoxic and hyperoxic conditions: a morphometric study. J Exp Zool 1992;262:291-8.
4. Cerda H, Rosander K. DNA damage in irradiated endothelial cells of the rat cerebral cortex. Protective action of cysteamine in vivo. Radiat Res 1983;95:317-26.
5. Choy H, Rodriguez F, Koester S, et al. Investigation of Taxol as a potential radiation sensitizer. Cancer 1993;71:3774-8.
6. D'Amato R. Quantification of angiogenesis inhibitors in animal models. In: Mousa SA, ed. Therapeutic implications and mechanisms of angiogenesis. Southborough, MA, USA: IBC USA Conferences, 1996:1.2.1.-8.
7. Denekamp J. Endothelial cell attack as a novel approach to cancer therapy. Cancer Top 1986;6:6-8.
8. Denekamp J. Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br J Radiol 1993;66:181-96.
9. Dordunoo S, Jackson J, Arsenault L, et al. Taxol encapsulation in poly(epsilon-caprolactone) microspheres. Cancer Chemother Pharmacol 1995;36:279-82.
10. Dunst J, Becker A, Lautenschlager C, et al. Anemia and elevated systemic levels of vascular endothelial growth factor. Strahlenther Onkol 2002;178:436-41.
11. Fajardo L. The unique physiology of endothelial cells and its implications in radiobiology. Front Radiat Ther Oncol. 1989;23:96-112.
12. Folkman J. Tumor angiogenesis. Adv Cancer Res 1985;43:175-203.
13. Giannopoulou E, Katsoris P, Parthymou A, et al. Amifostine protects blood vessels from the effects of ionizing radiation. Anticancer Res 2002;22:2821-6.
14. Glatt H, Vu P, Burger P, et al. Effect of irradiation on vascularization of corneas grafted onto chorioallantoic membranes. Invest Ophthalmol Vis Sci 1985;26:1533-42.
15. Gupta N, Hu LJ, Deen DF. Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiation. Int J Radiat Oncol Biol Phys 1997;37:885-95.
16. Hadjimichael C, Kardamakis D, Demopoulos J, et al. A modified chorioallantoic membrane assay for irradiation dose-response studies of angiogenesis and involvement of nitric oxide. J BUON 1999;4:393-8.
17. Hagino S, Itagaki H, Kato S, et al. Further evaluation of the quantitative chorioallantoic membrane test using trypan blue stain to predict the eye irritancy of chemicals. Toxic Vitro 1993;7:35-9.
18. Hall E. Radiobiology for the radiologist, 4th edn. Philadelphia: Lippincott, 2000:45-72.
19. Harris-Hooker S, Gadjusec C, Wight T, et al. Neovascular responses induced by cultured aortic endothelial cells. J Cell Physiol 1983;114:302-10.
20. Hatjikondi O, Ravazoula P, Kardamakis D, et al. In vivo experimental evidence that the nitric oxide pathway is involved in the X-ray-induced antiangiogenicity. Br J Cancer 1996;74:1916-23.
21. His W. Untersuchungen ueber die erste Anlage des Wirbelthierleibes. Leipzig: Vogel, 1868.
22. Horwitz S. Taxol (paclitaxel): mechanisms of action. Ann Oncol 1994;5: Suppl 6:S3-6.
23. Ingram M, Redpath L. Subadditive interaction of radiation and Taxol in vitro. Int J Radiat Oncol Biol Phys 1997;37:1139-44.
24. Klauber N, Parangi S, Flynn E, et al. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and Taxol. Cancer Res 1997;57:81-6.
25. Kortmann RD, Jeremic B, Weller M, et al. Radiochemotherapy of malignant gliomas in adults. Clinical experiences. Stahlenther Onkol 2003;179:219-32.
26. Lokeshwar BL, Farrell SM, Block NL. Enhancement of radiation response of prostatic carcinoma by Taxol: therapeutic potential for late-stage malignancy. Anticancer Res 1995;15:93-8.
27. Lutz W. Statistical methods as applied to immunological data. In: Weir D, ed. Handbook of experimental immunology. Oxford: Blackwell, 1978:1-29.
28. Maragoudakis M, Haralabopoulos G, Tsopanoglou N, et al. Validation of collagenous protein synthesis as an index for angiogenesis with the use of morphological methods. Microvasc Res 1995;50:215-22.
29. Maragoudakis M, Panoutsacopoulou M, Sarmonika M. Rate of basement membrane biosynthesis as an index to angiogenesis. Tissue Cell 1988;20:531-9.
30. Martin D, Fischer J. Radiation sensitivity of cultured rabbit aortic endothelial cells. Int J Radiat Oncol Biol Phys 1984;10:1903-6.
31. Pipili-Synetos E, Papageorgiou A, Sakkoula E, et al. Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Br J Pharmacol 1995;116:1829-34.
32. Plasswilm L, Hanjalic A, Hoeper J, et al. Microvessel density and endothelial cell proliferation after amifostine (Ethyol) administration in vivo. Anti-cancer Res 1999;19:4241-5.
33. Plasswilm L, Hoeper J, Cordes N, et al. Investigation of microvascular density after irradiation. Radiat Res 2002;151:454-60.
34. Plasswilm L, Hoper J, Sauer R. Radiobiologische In-vivo-Untersuchung zur Angiogenese am Dottersackgefäßsystem des Hühnerembryos. Strahlenther Onkol 1996;172:260-4.
35. Prionas S, Kowalski J, Fajardo L, et al. Effects of X-irradiation on angiogenesis. Radiat Res 1990;124:43-9.
36. Rhee J, Lee I, Song C. The clonogenic response of bovine aortic endothelial culture to radiation. Radiat Res 1986;106:182-9.
37. Sauer G, Deissler H, Kurzeder C, et al. New molecular targets of breast cancer therapy. Strahlenther Onkol 2002;178:123-33.
38. Schefler W. Statistics in biological sciences. Reading/MA: Addison-Wesley, 1969.
39. Schuck A, Muller SB, Kohler A, et al. Combined radiochemotherapy with paclitaxel in the treatment of malignant glioma. Strahlenther Onkol 2002;178:486-90.
40. Scialli A, DeSesso J, Goeringer G. Taxol and embryonic development in the chick. Teratog Carcinog Mutagen 1994;14:23-30.
41. Siamblis D, Karnabatidis D, Hadjikondi O, et al. A novel radiological approach for the experimental study of angiogenesis: angiography of the chick embryo and its chorioallantoic membrane. Eur J Radiol 1996;21:220-4.
42. Spencer C, Faulds D. Paclitaxel: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer. Drugs 1994;48:794-847.
43. Steren A, Sevin B, Perras J, et al. Taxol as a radiation sensitizer: a flow cytometric study. Gynecol Oncol 1993;50:89-93.
44. Strick D, Waycaster R, Montani J, et al. Morphometric measurements on chorioallantoic membrane vascularity: effects of hypoxia and hyperoxia. Am J Physiol 1991;260:H1385-9.
45. Teicher B, Dupis N, Kusomoto T, et al. Antiangiogenic agents can increase tumor oxygenation and response to radiation therapy. Radial Oncol Investig 1995;2:269-76.
46. Vacca A, Ribatti D, Iurlaro M, et al. Docetaxel versus paclitaxel for antiangiogenesis. J Hematother Stem Cell Res 2002;11:103-18.
47. Van Rijn J, van den Berg J, Meijer OW. Proliferation and clonal survival of human lung cancer cells treated with fractionated irradiation in combination with paclitaxel. Int J Radiat Oncol Biol Phys 1995;33:635-9.
48. Vogt H, Kolotas C, Martin T, et al. Concurrent paclitaxel/radiotherapy in locally advanced stage IIIA/B non-small cell lung cancer: results of a clinical phase I study. Semin Radial Oncol 1997;7: Suppl 1:S1-24.
49. Withers HR, Elkind MM. Microcolonies survival assay for cells of mouse intestinal mucosa exposed to radiation. Int J Radial Biol Rel Study Phys Chem Med 1970;17:261-7.